1. Home
  2. MNDR vs VBIO Comparison

MNDR vs VBIO Comparison

Compare MNDR & VBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mobile-health Network Solutions Class A Ordinary Shares

MNDR

Mobile-health Network Solutions Class A Ordinary Shares

HOLD

Current Price

$1.44

Market Cap

1.9M

Sector

N/A

ML Signal

HOLD

Logo Valion Bio Inc. Common Stock

VBIO

Valion Bio Inc. Common Stock

N/A

Current Price

$2.80

Market Cap

1.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MNDR
VBIO
Founded
2016
N/A
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9M
1.6M
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
MNDR
VBIO
Price
$1.44
$2.80
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
144.2K
22.2M
Earning Date
03-12-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$780,000.00
Revenue This Year
$608,852.40
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.40
$0.11
52 Week High
$5.42
$4.14

Technical Indicators

Market Signals
Indicator
MNDR
VBIO
Relative Strength Index (RSI) 39.90 61.18
Support Level $0.78 $0.30
Resistance Level $1.74 $4.14
Average True Range (ATR) 0.12 0.53
MACD 0.00 0.30
Stochastic Oscillator 18.60 69.73

Price Performance

Historical Comparison
MNDR
VBIO

About MNDR Mobile-health Network Solutions Class A Ordinary Shares

Mobile-health Network Solutions is a company engaged in providing telehealth solutions in terms of various matrices, such as the number of patient consultations per day and the ranking of its mobile application. It provides services on its MaNaDr platform, which is accessible via mobile application and website. The MaNaDr platform is a platform designed and created by doctors, for doctors and users, equipped with services like consultations with doctors, e-commerce pharma store, and others. The company's operating segments are Telemedicine and other services, and the Sale of medicine and medical devices. The majority of the company's revenue is derived from the Telemedicine and other services segment. Geographically, it derives revenue from Singapore.

About VBIO Valion Bio Inc. Common Stock

Valion Bio Inc is a late-stage biopharmaceutical company developing biologics that activate innate immune pathways for cytoprotection and immune modulation. Its main candidate, Entolimod, is a TLR5 agonist and also advances Entolasta, a next-generation TLR5 agonist, and targets the neutropenia oncology supportive care market.

Share on Social Networks: